← Evidence map

ReviewHereditary cancer in clinical practice2021

Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline.

Michelle Jacobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34565426